This inventor holds 1 USPTO granted patent. Top assignee: Biontech Se. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dennis Verzijl: Innovator in Binding Agents
Introduction
Dennis Verzijl is a notable inventor recognized for his contributions to the field of binding agents. He is currently associated with BioNTech SE, a leading biotechnology company. His work focuses on innovative solutions that have the potential to impact therapeutic applications significantly.
Latest Patents
Dennis Verzijl holds a patent titled "Binding Agents Binding to PD-L1 and CD137 and Use Thereof." This patent represents a significant advancement in the development of binding agents that can interact with specific proteins, which may lead to new therapeutic strategies.
Career Highlights
Throughout his career, Dennis has demonstrated a commitment to innovation and research. His work at BioNTech SE has positioned him as a key player in the biotechnology sector, contributing to the company's mission of developing groundbreaking therapies.
Collaborations
Dennis has collaborated with talented individuals such as Isil Altintas and David Satijn. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
In summary, Dennis Verzijl is an accomplished inventor whose work in binding agents is paving the way for future advancements in biotechnology. His contributions at BioNTech SE and his innovative patent highlight his significant role in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile